Obesity Treatment Using an Internet-delivered Intervention Based on the Diabetes Prevention Program in Mexican Adults
NCT ID: NCT03629301
Last Updated: 2021-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2018-09-17
2019-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Obesity Treatment With a Very Low Energy Diet in Mexican Adults
NCT05631535
Translational Study for Obesity Management in Mexican Adults Using the "Group Lifestyle Balance Program"
NCT02537704
Evaluation of the Planetary Health Diet Included in a Lifestyle Program in Overweight or Obese Mexican Adults.
NCT05309044
Evaluation of the Plant-based Approaches to Stop Obesity Diet for the Treatment of Overweight and Obesity
NCT03608176
Virtual Environments For Supporting Obesity Treatment
NCT01394393
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ID-DPP group
Internet-delivered intervention based on the DPP
ID-DPP group
This group will receive a 6 month long online behavioral change protocol adapted from the Diabetes Prevention Program. It includes 18 sessions, 12 delivered weekly (during the first 3 months) and 6 delivered biweekly (during the last 3 month period). A web page will be used to deliver the sessions, while the nutritional counseling will be delivered using video calls via Facebook chat. Participants will receive an hypocaloric (1200-1800 kcal, carbohydrates: 45-65%, fats: 20-35% and protein: 10-35%), personalized diet.
Wait-list Group
Wait-list Group
This group will only receive written information with recommendations on healthy eating. When the study has finished this group will receive a behavioral change protocol with nutritional counseling using a face-to-face format.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ID-DPP group
This group will receive a 6 month long online behavioral change protocol adapted from the Diabetes Prevention Program. It includes 18 sessions, 12 delivered weekly (during the first 3 months) and 6 delivered biweekly (during the last 3 month period). A web page will be used to deliver the sessions, while the nutritional counseling will be delivered using video calls via Facebook chat. Participants will receive an hypocaloric (1200-1800 kcal, carbohydrates: 45-65%, fats: 20-35% and protein: 10-35%), personalized diet.
Wait-list Group
This group will only receive written information with recommendations on healthy eating. When the study has finished this group will receive a behavioral change protocol with nutritional counseling using a face-to-face format.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Residents of the city of Hermosillo, Sonora
* Overweight or obese (BMI ≥ 25 and ≤45)
* Internet access at home
* Basic computer skills
* Facebook active account
* Candidates must make records of their food consumption for 5 days.
Exclusion Criteria
* Consumption of more than 14 alcoholic beverages per week (equivalent to 280 g of alcohol)
* Diagnosis of psychiatric conditions that could prevent adherence to treatment
* Previous diagnosis of medical conditions with significant effect on body weight
* Diagnosis of diabetes
* Systolic blood pressure\> 160 mm / Hg
* Pregnant women who are breastfeeding or who plan to become pregnant during the study period
* Consumption of medications with an effect on body weight such as metformin, orlistat or glucocorticoids.
* Participating in another program to reduce weight or performing structured physical exercise other than walking\> 180 min / week
* Plan to participate in some treatment for weight loss during the study
* Any other condition in which weight loss or physical activity is contraindicated
* Previous diagnosis of kidney failure, cancer or any other condition that requires special treatment
* Relatives participating in the study
* Have plans to change residence
* Criteria of the researcher - for clinical reasons or adherence to the protocol
* Weight loss\>5% of total body weight in the previous 4 months
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Sonora
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rolando Giovanni Díaz Zavala
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro de Promoción de Salud Nutricional (CPSN)
Hermosillo, Sonora, Mexico
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ruelas AL, Martinez Contreras TJ, Esparza Romero J, Diaz Zavala RG, Candia Plata MDC, Hingle M, Armenta Guirado B, Haby MM. Factors influencing adults to drop out of intensive lifestyle interventions for weight loss. Transl Behav Med. 2023 Apr 15;13(4):245-254. doi: 10.1093/tbm/ibac112.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
USO313003634
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.